Transplantation of a healthy bone marrow mitigates liver metabolic and inflammatory alterations in hypertriglyceridemic animals subjected to myocardial infarction
Hypertriglyceridemia (HTG) is associated with deleterious effects in both the liver (i.e., metabolic dysfunction-associated steatotic liver disease) and the heart. Transplantation of a healthy BM to whole-body irradiated HTG recipients has been shown to improve cardiac healing post-myocardial infarction (MI). However, how healthy BM transplantation affects the hepatic response of HTG animals is poorly understood. In this study we have determined the impact of healthy BM transplantation on the liver of HTG rats that had an induced MI. Forty-two Wistar rats were randomly assigned to receive: a high-sucrose diet to induce HTG or a normolipemic (NL) chow. After three weeks, crossed-BM transplants were conducted after total body irradiation resulting in three groups: NL-BM/HTG-recipient, NL-BM/NL-recipient, and HTG-BM/HTG-recipient. All animals continued their diets throughout the study. At three weeks, MI was induced (transient coronary ligation), and animals were sacrificed after five days. Blood and liver samples were collected for transcriptomic, lipid, molecular and histological analyses. Liver transcriptomics revealed distinct profiles across the experimental groups. Principal component analysis suggested partial overlap and mixed clustering of NL-BM/HTG-recipient and NL-BM/NL-recipient animals, whereas HTG-BM/HTG-recipients showed some degree of separation. 106 differentially expressed genes and 30 potentially enriched pathways were found between HTG-BM/HTG-recipients and NL-BM/HTG-recipients, whereas 54 genes differed between HTG-BM/HTG-recipients and NL-BM/NL-recipients and 14 diet-associated pathways were significantly altered. HTG-BM/HTG-recipients showed an upregulation of Uvrag , Gys2 , Ugp-2 , Glut2 , Il1r1 , Tifa , Casp3 , Socs3 , Ikbip , Lepr and Nr3c1 , and a downregulation of Hmgcs1 , Idi1 , Sqle , Gpam , Ces1d , Fat1 , and Gckr as compared to NL-BM/HTG-recipients and NL-BM/NL-recipients. Selected genes and proteins were further assessed by qPCR and Western blotting, respectively. Histological analysis revealed a significant reduction in liver steatosis in NL-BM/HTG-recipients compared to HTG-BM/HTG-recipients. Liver IL-1β and IL-6 expression and circulating levels of CRP were lower in NL-BM/HTG-recipients and NL-BM/NL-recipients, as compared to HTG-BM/HTG-recipients. Hepatic content of CD68 + iNOS + and CD68 + TREM2 + macrophages was higher in HTG-BM/HTG-recipients compared to the other groups and, NL-BM/HTG-recipients showed higher numbers of CD68 + MRC1 + macrophages vs. the other two groups. Alanine aminotransferase serum levels were normalized in NL-BM/HTG-recipients three weeks post-BM transplant, whereas no variations were observed in the other two groups. Transplanting healthy BM into HTG rats normalizes gene expression and protein levels of key molecules for lipid metabolism, glucose/glycogen handling, and metabolic syndrome development, limits steatosis and reduces liver inflammatory markers, supporting BM-dependent modulation of the hepatic response.
Authors
- Lina Badimón (ORCID: https://orcid.org/0000-0002-9162-2459)
- Teresa Padró (ORCID: https://orcid.org/0000-0003-1921-954X)
- Sebastià Alcover (ORCID: https://orcid.org/0000-0003-3699-1769)
- Anna Planavila (ORCID: https://orcid.org/0000-0001-5474-4724)
- Gemma Sancho (ORCID: https://orcid.org/0000-0003-2266-6172)
- Gemma Vilahur (ORCID: https://orcid.org/0000-0002-2828-8873)
- Lisaidy Ramos-Regalado (ORCID: https://orcid.org/0009-0004-3512-8474)
- Josep Balart (ORCID: https://orcid.org/0000-0002-1173-7556)
- Gabriela O. Girón (ORCID: https://orcid.org/0009-0009-4753-0985)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Instituto de Salud Carlos III (ES)
- Spanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (ES)
- Hospital de Sant Pau (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Centro de Investigación Biomédica en Red (ES)
- Institut de Recerca Sant Pau (ES)
- Institut de Biomedicina de la Universitat de Barcelona (ES)
- Universitat de Barcelona (ES)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1186/s12967-026-09249-w
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Generalitat de Catalunya
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III
- European Regional Development Fund
- Agencia Estatal de Investigación